Clinical Trial: Treatment With Crizotinib Single Patient Expanded Access IND 134375

Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access:   Available for Individual Patients

Official Title: Treatment With Crizotinib Single Patient Expanded Access IND 134375

Brief Summary:

Two year old male with a new diagnosis of Inflammatory Myofibroblastic Tumour. The patient presented with 2 months of intermittent fever and 1-2 weeks of abdominal distention and constipation. An abdominal mass was palpable on exam and US concerning was for neoplasm of abdomen.

Treatment with Crizotinib will be utilized to reduce the size of the lesion and create more optimal tissue plains between vital structures prior to attempted surgical resection would greatly reduce potential morbidity for this patient.

Detailed Summary:
Sponsor: University of Pittsburgh

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Pittsburgh

Dates:
Date Received: March 14, 2017
Date Started:
Date Completion:
Last Updated: March 14, 2017
Last Verified: March 2017